Ayr Strategies Inc. is a vertically-integrated multi-state operator in cannabis sector in the United States. The company, through its subsidiaries, engages in the cultivation, manufacture, and retailer of cannabis products and branded cannabis packaged goods. Ayr Strategies Inc. is based in New York, New York.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
PhoneN/A
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Ayr Strategies (OTCMKTS:AYRSF) Frequently Asked Questions
What is Ayr Strategies' stock symbol?
Ayr Strategies trades on the OTCMKTS under the ticker symbol "AYRSF."
What price target have analysts set for AYRSF?
1 equities research analysts have issued 12-month target prices for Ayr Strategies' shares. Their forecasts range from $18.00 to $18.00. On average, they expect Ayr Strategies' stock price to reach $18.00 in the next year. This suggests a possible upside of 127.1% from the stock's current price. View Analyst Price Targets for Ayr Strategies.
What is the consensus analysts' recommendation for Ayr Strategies?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ayr Strategies in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Ayr Strategies.
Has Ayr Strategies been receiving favorable news coverage?
News stories about AYRSF stock have been trending neutral on Saturday, InfoTrie Sentiment reports. InfoTrie identifies negative and positive press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Ayr Strategies earned a daily sentiment score of 0.2 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near term. View News Stories for Ayr Strategies.
Who are some of Ayr Strategies' key competitors?
Some companies that are related to Ayr Strategies include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), cbdMD (YCBD), Charlotte's Web (CWBHF), Choom (CHOOF) and Cipher Pharmaceuticals (CPHRF).
What other stocks do shareholders of Ayr Strategies own?
Who are Ayr Strategies' key executives?
Ayr Strategies' management team includes the folowing people:
- Mr. Jonathan Everett Sandelman, Chairman, CEO & Corp. Sec. (Age 61)
- Mr. Mark Smith, Exec. Vice Chairman
- Ms. Jennifer Adele Drake, COO & Interim CFO
- Mr. Mark Pitchford, Chief Devel. Officer
How do I buy shares of Ayr Strategies?
Shares of AYRSF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Ayr Strategies' stock price today?
One share of AYRSF stock can currently be purchased for approximately $7.93.
What is Ayr Strategies' official website?
MarketBeat Community Rating for Ayr Strategies (OTCMKTS AYRSF)
MarketBeat's community ratings are surveys of what our community members think about Ayr Strategies and other stocks. Vote "Outperform" if you believe AYRSF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AYRSF will underperform the S&P 500 over the long term. You may vote once every thirty days.
